Growth Metrics

Baxter International (BAX) EBIAT (2016 - 2024)

Baxter International (BAX) has disclosed EBIAT for 16 consecutive years, with -$512.0 million as the latest value for Q4 2024.

  • On a quarterly basis, EBIAT rose 76.59% to -$512.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $246.0 million, a 35.91% increase, with the full-year FY2025 number at -$900.0 million, down 38.67% from a year prior.
  • EBIAT was -$512.0 million for Q4 2024 at Baxter International, down from $1.0 billion in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $2.5 billion in Q3 2023 to a low of -$2.9 billion in Q3 2022.
  • A 5-year average of -$27.7 million and a median of $124.5 million in 2020 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: crashed 1751.85% in 2022, then skyrocketed 4000.0% in 2024.
  • Baxter International's EBIAT stood at $176.0 million in 2020, then plummeted by 115.34% to -$27.0 million in 2021, then plummeted by 1751.85% to -$500.0 million in 2022, then plummeted by 337.4% to -$2.2 billion in 2023, then soared by 76.59% to -$512.0 million in 2024.
  • Per Business Quant, the three most recent readings for BAX's EBIAT are -$512.0 million (Q4 2024), $1.0 billion (Q3 2024), and -$314.0 million (Q2 2024).